Clinical Trial Update: Catestatin as a Novel Biomarker for Cardiovascular and Microvascular Involvement in Systemic Sclerosis

View source ↗

Summary

This clinical trial investigates catestatin as a biomarker for cardiovascular and microvascular involvement in systemic sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: Assiut University | Conditions: Systemic Sclerosis | Status: NOT_YET_RECRUITING